Survival Trends and Prognostic Modeling in ALK‐Positive Anaplastic Large Cell Lymphoma: A Population‐Based Study in the Brentuximab Vedotin Era
ABSTRACT Background ALK‐positive anaplastic large cell lymphoma (ALK+ ALCL) is a rare subtype of peripheral T‐cell lymphoma with traditionally favorable prognosis. The introduction of brentuximab vedotin (BV) has significantly impacted treatment outcomes, but the long‐term survival trends and predic...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2026-03-01
|
| Серія: | Cancer Medicine |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/cam4.71695 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|